Sep 2026· Neurobiology of Aging· Vol 169, pp.
100-109
· 0 citations· 77 references
Medicine
TL;DR
Higher levels of peripheral pro-inflammatory markers are associated with white matter microstructure associated with multi-shell dMRI Neurite Orientation Dispersion and Density Imaging (NODDI), supporting the sensitivity of these dMRI-based metrics to inflammatory processes.
Abstract
Chronic inflammation is a common feature of aging and is observed across various age-related neurodegenerative diseases, including Alzheimer's disease (AD). Diffusion magnetic resonance imaging (dMRI) metrics of white matter microstructure are hypothesized to be sensitive to inflammation, though few studies have assessed this relationship in non-clinical populations. This cross-sectional study of 457 dementia-free older adults (Mage=63.82) examined associations of plasma markers related to inflammation with white matter microstructure metrics from multi-shell dMRI Neurite Orientation Dispersion and Density Imaging (NODDI) and conventional, single-shell dMRI metrics. Plasma inflammatory markers included high-sensitivity C-reactive protein (CRP), a composite of pro-inflammatory cytokines, and glial fibrillary acidic protein (GFAP), a measure of astrocytic activation. Higher cytokine composite levels were associated with higher cerebral free water fraction (FWF) and higher cerebellar peduncle orientation dispersion index (ODI). Higher CRP was associated with higher cerebral and cerebellar ODI, which was non-significant after adjusting for additional demographics and vascular risk factors. Higher GFAP was associated with lower cerebral FWF and lower cerebral and cerebellar neurite density index (NDI). The only significant association with conventional DTI metrics was between higher cytokine composite levels and higher cerebral mean diffusivity (MD). Results were consistent after accounting for plasma AD biomarkers. Thus, higher levels of peripheral pro-inflammatory markers are associated with white matter microstructure (FWF, ODI, NDI, and MD), supporting the sensitivity of these dMRI-based metrics to inflammatory processes. Additionally, the sensitivity of dMRI-based measures to inflammation may differ by inflammatory marker types, with multi-shell approaches like NODDI providing information beyond conventional, single-shell dMRI.
A link between systemic inflammatory burden and hippocampal vulnerability is supported, while relationships with AD pathology and clinical progression warrant further investigation.
Hong-Sheng Xie, Yu-Hao Li, Ruo-Qiu Gan et al.· Progress in Neuro-psychophar...· 0 citations
Aim: We examined how routine inflammation-related biomarkers vary across Alzheimer disease (AD) severity and whether they are independently associated with moderate-to-severe disease.
Materials and Methods: This retrospective cross-sectional study included outpatients aged ≥ 65 years with clinically diagnosed AD. Sever...
M. Levent, M. Eşme, Cafer Balcı et al.· The Atlantic Journal of Medi...· 0 citations
In this large longitudinal sample of asymptomatic individuals, the Aβ-dominant biomarker component showed the strongest association with longitudinal GM atrophy and cognitive decline, beyond the effects of tau pathophysiology and neuroaxonal injury.
W. Pelkmans, R. Cacciaglia, Michalis Kassinopoulos et al.· Molecular Neurodegeneration· 0 citations
Abstract INTRODUCTION Elevated cerebrospinal fluid (CSF) inflammatory proteins have been reported in Alzheimer's disease (AD), yet whether they reflect peripheral immune cell infiltration or central nervous system (CNS)–intrinsic pathological processes remains unclear. We tested whether AD exhibits a distinct CSF prote...
Sina Zaic, T. König, O. Keritam et al.· Alzheimer's & Dementia· 0 citations
It is suggested that higher local subcortical iron accumulation contributes to low-grade neuroinflammation in middle-aged and older adults, but only brain iron accounts for cognitive and motor decline, indicating that low-grade neuroinflammation may partly constitute an adaptive response to the deleterious effects of i...
G. Kalpouzos, F. Falahati, Jonatan Malmros et al.· Brain, behavior, and immunit...· 0 citations
Background Identifying candidate biomarkers for preclinical dementia could improve our understanding of underlying biological pathways leading to vascular brain injury (VBI) and neurodegeneration. Objective To identify plasma protein markers of MRI markers of VBI and amyloid- and tau-PET burden in cognitively healthy a...
Martin D. Mulligan, Rui-Qi Wang, Qiong Yang et al.· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.